Cargando…
Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153296/ https://www.ncbi.nlm.nih.gov/pubmed/22069684 http://dx.doi.org/10.3390/toxins2092258 |
_version_ | 1782209882465763328 |
---|---|
author | Placzek, Richard Siebold, Dagmar Funk, Julia F. |
author_facet | Placzek, Richard Siebold, Dagmar Funk, Julia F. |
author_sort | Placzek, Richard |
collection | PubMed |
description | The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however, reduced due to a better understanding of the relationship between dosage, severe side effects and the kind of anesthesia used. To combine safety and efficacy, the trend tends to a lower dosage, but combined with a more specific selection of injected muscles. The treatment of these key-muscles takes into account the best support for motor development to attain each individual motor milestone. |
format | Online Article Text |
id | pubmed-3153296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-31532962011-11-08 Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy Placzek, Richard Siebold, Dagmar Funk, Julia F. Toxins (Basel) Review The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however, reduced due to a better understanding of the relationship between dosage, severe side effects and the kind of anesthesia used. To combine safety and efficacy, the trend tends to a lower dosage, but combined with a more specific selection of injected muscles. The treatment of these key-muscles takes into account the best support for motor development to attain each individual motor milestone. MDPI 2010-08-27 /pmc/articles/PMC3153296/ /pubmed/22069684 http://dx.doi.org/10.3390/toxins2092258 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Placzek, Richard Siebold, Dagmar Funk, Julia F. Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title | Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title_full | Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title_fullStr | Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title_full_unstemmed | Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title_short | Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy |
title_sort | development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153296/ https://www.ncbi.nlm.nih.gov/pubmed/22069684 http://dx.doi.org/10.3390/toxins2092258 |
work_keys_str_mv | AT placzekrichard developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy AT siebolddagmar developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy AT funkjuliaf developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy |